AKT1 and hepatocellular carcinoma: Consistently, PTPN6 overexpression inhibits the proliferation, migration, invasion and tumorigenicity of HCC cells by suppressing multiple oncogenic pathways, including janus kinase (JAK)/STAT, NF-κB and AKT signaling pathways (68).